Do changes in health reveal the possibility of undiagnosed pancreatic cancer? Development of a risk-prediction model based on healthcare claims data

被引:23
作者
Baecker, Aileen [1 ]
Kim, Sungjin [2 ]
Risch, Harvey A. [3 ]
Nuckols, Teryl K. [2 ]
Wu, Bechien U. [4 ]
Hendifar, Andrew E. [2 ]
Pandol, Stephen J. [2 ]
Pisegna, Joseph R. [5 ]
Jeon, Christie Y. [1 ,2 ,5 ]
机构
[1] Univ Calif Los Angeles, Fielding Sch Publ Hlth, Los Angeles, CA 90095 USA
[2] Cedars Sinai Med Ctr, Los Angeles, CA 90048 USA
[3] Yale Sch Publ Hlth, New Haven, CT USA
[4] Kaiser Permanente Southern Calif, Res & Evaluat, Pasadena, CA USA
[5] Vet Affairs Greater Los Angeles Healthcare Syst, Los Angeles, CA 90073 USA
关键词
POOLED ANALYSIS; EPIDEMIOLOGY; METAANALYSIS; POPULATION; DIAGNOSIS;
D O I
10.1371/journal.pone.0218580
中图分类号
O [数理科学和化学]; P [天文学、地球科学]; Q [生物科学]; N [自然科学总论];
学科分类号
07 ; 0710 ; 09 ;
摘要
Background and objective Early detection methods for pancreatic cancer are lacking. We aimed to develop a prediction model for pancreatic cancer based on changes in health captured by healthcare claims data. Methods We conducted a case-control study on 29,646 Medicare-enrolled patients aged 68 years and above with pancreatic ductal adenocarcinoma (PDAC) reported to the Surveillance Epidemiology an End Results (SEER) tumor registries program in 2004-2011 and 88,938 age and sex-matched controls. We developed a prediction model using multivariable logistic regression on Medicare claims for 16 risk factors and pre-diagnostic symptoms of PDAC present within 15 months prior to PDAC diagnosis. Claims within 3 months of PDAC diagnosis were excluded in sensitivity analyses. We evaluated the discriminatory power of the model with the area under the receiver operating curve (AUC) and performed cross-validation by bootstrapping. Results The prediction model on all cases and controls reached AUC of 0.68. Excluding the final 3 months of claims lowered the AUC to 0.58. Among new-onset diabetes patients, the prediction model reached AUC of 0.73, which decreased to 0.63 when claims from the final 3 months were excluded. Performance measures of the prediction models was confirmed by internal validation using the bootstrap method. Conclusion Models based on healthcare claims for clinical risk factors, symptoms and signs of pancreatic cancer are limited in classifying those who go on to diagnosis of pancreatic cancer and those who do not, especially when excluding claims that immediately precede the diagnosis of PDAC.
引用
收藏
页数:16
相关论文
共 39 条
[1]   Factors That Affect Risk for Pancreatic Disease in the General Population: A Systematic Review and Meta-analysis of Prospective Cohort Studies [J].
Alsamarrai, Ammar ;
Das, Stephanie L. M. ;
Windsor, John A. ;
Petrov, Maxim S. .
CLINICAL GASTROENTEROLOGY AND HEPATOLOGY, 2014, 12 (10) :1635-U99
[2]  
American Cancer Society, 2016, CANC FACTS FIG
[3]  
[Anonymous], 2018, SURV EP END RES SEER
[4]  
[Anonymous], 2001, REGRESSION MODELING
[5]   Diabetes mellitus and risk of pancreatic cancer: A meta-analysis of cohort studies [J].
Ben, Qiwen ;
Xu, Maojin ;
Ning, Xiaoyan ;
Liu, Jun ;
Hong, Shangyou ;
Huang, Wen ;
Zhang, Huagao ;
Li, Zhaoshen .
EUROPEAN JOURNAL OF CANCER, 2011, 47 (13) :1928-1937
[6]   Diabetes, antidiabetic medications, and pancreatic cancer risk: an analysis from the International Pancreatic Cancer Case-Control Consortium [J].
Bosetti, C. ;
Rosato, V. ;
Li, D. ;
Silverman, D. ;
Petersen, G. M. ;
Bracci, P. M. ;
Neale, R. E. ;
Muscat, J. ;
Anderson, K. ;
Gallinger, S. ;
Olson, S. H. ;
Miller, A. B. ;
Bueno-de-Mesquita, H. Bas ;
Scelo, G. ;
Janout, V. ;
Holcatova, I. ;
Lagiou, P. ;
Serraino, D. ;
Lucenteforte, E. ;
Fabianova, E. ;
Ghadirian, P. ;
Baghurst, P. A. ;
Zatonski, W. ;
Foretova, L. ;
Fontham, E. ;
Bamlet, W. R. ;
Holly, E. A. ;
Negri, E. ;
Hassan, M. ;
Prizment, A. ;
Cotterchio, M. ;
Cleary, S. ;
Kurtz, R. C. ;
Maisonneuve, P. ;
Trichopoulos, D. ;
Polesel, J. ;
Duell, E. J. ;
Boffetta, P. ;
La Vecchia, C. .
ANNALS OF ONCOLOGY, 2014, 25 (10) :2065-2072
[7]   A Clinical Prediction Model to Assess Risk for Pancreatic Cancer Among Patients With New-Onset Diabetes [J].
Boursi, Ben ;
Finkelman, Brian ;
Giantonio, Bruce J. ;
Haynes, Kevin ;
Rustgi, Anil K. ;
Rhim, Andrew D. ;
Mamtani, Ronac ;
Yang, Yu-Xiao .
GASTROENTEROLOGY, 2017, 152 (04) :840-+
[8]   Probability of pancreatic cancer following diabetes: A population-based study [J].
Chari, ST ;
Leibson, CL ;
Rabe, KG ;
Ransom, J ;
De Andrade, M ;
Petersen, GM .
GASTROENTEROLOGY, 2005, 129 (02) :504-511
[9]  
Cylus Jonathan, 2015, Health Syst Transit, V17, P1
[10]   Pancreatitis and pancreatic cancer risk: a pooled analysis in the International Pancreatic Cancer Case-Control Consortium (PanC4) [J].
Duell, E. J. ;
Lucenteforte, E. ;
Olson, S. H. ;
Bracci, P. M. ;
Li, D. ;
Risch, H. A. ;
Silverman, D. T. ;
Ji, B. T. ;
Gallinger, S. ;
Holly, E. A. ;
Fontham, E. H. ;
Maisonneuve, P. ;
Bueno-de-Mesquita, H. B. ;
Ghadirian, P. ;
Kurtz, R. C. ;
Ludwig, E. ;
Yu, H. ;
Lowenfels, A. B. ;
Seminara, D. ;
Petersen, G. M. ;
La Vecchia, C. ;
Boffetta, P. .
ANNALS OF ONCOLOGY, 2012, 23 (11) :2964-2970